Page last updated: 2024-11-06

prednisolone and Local Neoplasm Recurrence

prednisolone has been researched along with Local Neoplasm Recurrence in 129 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"The clinical analysis indicated that giving 6 days of daily low-dose prednisolone at the time of an upper respiratory tract infection does not reduce the risk of relapse of steroid-sensitive nephrotic syndrome in UK children."9.51Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT. ( Afentou, N; Bockenhauer, D; Brettell, EA; Christian, MT; Cook, W; Finlay, ER; Frew, E; Gilbert, RD; Hall, AS; Hegde, S; Ives, N; Jones, C; Khan, AR; Koziell, A; Maxwell, H; McKeever, K; Mehta, S; Milford, DV; Saleem, MA; Webb, NJ; Woolley, RL, 2022)
"Fourteen patients with recurrent breast cancer were treated with a combination of mitoxantrone (10 mg/m2 iv, day 1), vincristine (1 mg/m2 iv, day 1) and prednisolone (30 mg/day day 1-7)."9.08[Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer]. ( Fukunaga, M; Iba, T; Kidokoro, A; Momose, F; Yagi, Y, 1995)
"A prospective randomised trial was performed in patients given HLA-identical sibling bone marrow transplants for haematological malignancy comparing the combination of cyclosporin and methotrexate (CM) (n = 20) with the combination of cyclosporin, methotrexate and prednisolone (CMP) (n = 21) as prophylaxis for graft-versus-host disease (GVHD)."9.07A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy. ( Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S, 1991)
"To determine the effect of prednisolone on severe hypercalcaemia in women with metastatic breast cancer, 30 patients with serum ionized calcium above 1."9.07Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study. ( Ejlertsen, B; Holmegaard, SN; Krarup-Hansen, A; Kristensen, B; Mouridsen, H; Transbøl, I, 1992)
"Objectives The goals of this retrospective study were to evaluate the use of mechlorethamine, vincristine, melphalan and prednisolone (MOMP) chemotherapy for rescue of feline lymphoma, to describe the protocol's toxicity and to determine prognostic indicators for progression-free survival."7.88Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. ( Martin, OA; Price, J, 2018)
"We analyzed the treatment responses, toxicities, and survival outcomes of patients with relapsed or refractory multiple myeloma who received daily thalidomide, cyclophosphamide, and dexamethasone (CTD) or daily thalidomide, melphalan, and prednisolone (MTP) at 17 medical centers in Korea."7.85Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study. ( Choi, YS; Eom, HS; Han, JJ; Kang, HJ; Kim, HJ; Kim, K; Kim, MK; Kim, SH; Kwon, J; Lee, JH; Lee, JJ; Lee, JO; Lee, WS; Min, CK; Moon, JH; Yoon, DH; Yoon, SS, 2017)
"The administration of oral prednisolone using a standardized protocol of 3 mg/kg given once daily for 1 month, followed by a taper until the infant is 10 months of age, is an effective treatment for infantile hemangioma."7.77Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. ( Couto, RA; Greene, AK, 2011)
"A group of 23 patients with breast cancer were given one course of the following regimen every 3 weeks: mitoxantrone hydrochloride (8 mg/m(2) i."7.72Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer. ( Aoki, T; Katsumata, K; Koyanagi, Y; Kusama, M; Tomioka, H, 2003)
"We treated fifteen patients with recurrent breast cancer by a combination of mitoxantrone (8 mg/m i."7.69[Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer]. ( Katsumata, K; Kawasaki, M; Koyanagi, Y; Kusama, M; Moriwaki, R; Murano, A; Nagakawa, Y; Ogata, T; Shibata, K; Yamamoto, K, 1997)
"The effects of combination chemotherapy including mitoxantrone (MXN) "M-VEMFH" for advanced breast cancer were studied."7.67[Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer]. ( Hoshino, A; Ito, Y; Kamiya, O; Kinoshita, T; Kojima, T; Nagata, K; Ohara, K; Sugiura, I, 1985)
"We have recently had a case of a patient with primary malignant lymphoma in whom the diagnosis was difficult and prednisolone was remarkably effective."7.66[A case of primary malignant lymphoma of the brain which showed a remarkable response to prednisolone]. ( Aki, T; Ichikizaki, K; Iwata, T; Nakamura, T; Nakano, S; Toya, S, 1982)
"Multiple myeloma is a malignancy of plasma cells with around 6000 new cases per year in the UK."7.11MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma. ( Auner, HW; Boyd, K; Brown, S; Garg, M; Hall, A; Kaiser, M; Kendall, J; Roberts, S, 2022)
"The clinical analysis indicated that giving 6 days of daily low-dose prednisolone at the time of an upper respiratory tract infection does not reduce the risk of relapse of steroid-sensitive nephrotic syndrome in UK children."5.51Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT. ( Afentou, N; Bockenhauer, D; Brettell, EA; Christian, MT; Cook, W; Finlay, ER; Frew, E; Gilbert, RD; Hall, AS; Hegde, S; Ives, N; Jones, C; Khan, AR; Koziell, A; Maxwell, H; McKeever, K; Mehta, S; Milford, DV; Saleem, MA; Webb, NJ; Woolley, RL, 2022)
"In order to reduce toxic effects while attaining maximal therapeutic effects, epirubicin 10 mg/day, cyclophosphamide 100 mg/day and prednisolone 10 mg/day were administered through in indwelling catheter inserted into the internal mammary artery and/or subclavian artery for 3-4 weeks, employing the implantable port system for the treatment of unresectable breast cancer and recurrent cancer."5.08[Intra-arterial infusion chemotherapy for breast cancer]. ( Hamada, E; Ikawa, M; Matsumoto, Y; Miura, T; Murata, M; Nakasato, S; Takaki, S; Terakado, H; Watanabe, Y, 1996)
"Fourteen patients with recurrent breast cancer were treated with a combination of mitoxantrone (10 mg/m2 iv, day 1), vincristine (1 mg/m2 iv, day 1) and prednisolone (30 mg/day day 1-7)."5.08[Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer]. ( Fukunaga, M; Iba, T; Kidokoro, A; Momose, F; Yagi, Y, 1995)
"A prospective randomised trial was performed in patients given HLA-identical sibling bone marrow transplants for haematological malignancy comparing the combination of cyclosporin and methotrexate (CM) (n = 20) with the combination of cyclosporin, methotrexate and prednisolone (CMP) (n = 21) as prophylaxis for graft-versus-host disease (GVHD)."5.07A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy. ( Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S, 1991)
"To determine the effect of prednisolone on severe hypercalcaemia in women with metastatic breast cancer, 30 patients with serum ionized calcium above 1."5.07Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study. ( Ejlertsen, B; Holmegaard, SN; Krarup-Hansen, A; Kristensen, B; Mouridsen, H; Transbøl, I, 1992)
"Objectives The goals of this retrospective study were to evaluate the use of mechlorethamine, vincristine, melphalan and prednisolone (MOMP) chemotherapy for rescue of feline lymphoma, to describe the protocol's toxicity and to determine prognostic indicators for progression-free survival."3.88Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. ( Martin, OA; Price, J, 2018)
"We analyzed the treatment responses, toxicities, and survival outcomes of patients with relapsed or refractory multiple myeloma who received daily thalidomide, cyclophosphamide, and dexamethasone (CTD) or daily thalidomide, melphalan, and prednisolone (MTP) at 17 medical centers in Korea."3.85Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study. ( Choi, YS; Eom, HS; Han, JJ; Kang, HJ; Kim, HJ; Kim, K; Kim, MK; Kim, SH; Kwon, J; Lee, JH; Lee, JJ; Lee, JO; Lee, WS; Min, CK; Moon, JH; Yoon, DH; Yoon, SS, 2017)
"The administration of oral prednisolone using a standardized protocol of 3 mg/kg given once daily for 1 month, followed by a taper until the infant is 10 months of age, is an effective treatment for infantile hemangioma."3.77Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol. ( Couto, RA; Greene, AK, 2011)
"A 42-year-old married woman with a history of Mayer-Rokitansky-Küster-Hauser syndrome, an established neovagina, and complete clinical remission of cutaneous T-cell lymphoma (stage T4) treated with bleomycin, cyclophosphamide, doxorubicin, vincristine and prednisolone had suffered from abdominal pain."3.76Vaginal obliteration in a woman with a history of cutaneous T-cell lymphoma: the results of combined chemotherapy-induced gonadal toxicity and lymphoma relapse. ( Lee, WL; Pan, CC, 2010)
"A consecutive series of 173 women, with data available for 166 of these, presenting with large and locally advanced breast cancer (T2>/=4 cm, T3, T4, or N2) were treated with primary chemotherapy comprising cyclophosphamide, vincristine, doxorubicin, and prednisolone and then surgery (either conservation or mastectomy with axillary surgery) followed by radiotherapy were examined."3.72Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. ( Heys, SD; Hutcheon, AW; McIntosh, SA; Miller, ID; Ogston, KN; Payne, S; Sarkar, TK, 2003)
"A group of 23 patients with breast cancer were given one course of the following regimen every 3 weeks: mitoxantrone hydrochloride (8 mg/m(2) i."3.72Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer. ( Aoki, T; Katsumata, K; Koyanagi, Y; Kusama, M; Tomioka, H, 2003)
"Nine patients with stage III and stage IV thymoma were treated with cisplatin, vincristine, lomustine, cyclophosphamide and prednisolone."3.69Combination chemotherapy with a five-drug regimen for invasive thymoma. ( Bjerrum, OW; Daugaard, G; Kiss, K, 1996)
"We treated fifteen patients with recurrent breast cancer by a combination of mitoxantrone (8 mg/m i."3.69[Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer]. ( Katsumata, K; Kawasaki, M; Koyanagi, Y; Kusama, M; Moriwaki, R; Murano, A; Nagakawa, Y; Ogata, T; Shibata, K; Yamamoto, K, 1997)
"The effects of combination chemotherapy including mitoxantrone (MXN) "M-VEMFH" for advanced breast cancer were studied."3.67[Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer]. ( Hoshino, A; Ito, Y; Kamiya, O; Kinoshita, T; Kojima, T; Nagata, K; Ohara, K; Sugiura, I, 1985)
"We have recently had a case of a patient with primary malignant lymphoma in whom the diagnosis was difficult and prednisolone was remarkably effective."3.66[A case of primary malignant lymphoma of the brain which showed a remarkable response to prednisolone]. ( Aki, T; Ichikizaki, K; Iwata, T; Nakamura, T; Nakano, S; Toya, S, 1982)
"Multiple myeloma is a malignancy of plasma cells with around 6000 new cases per year in the UK."3.11MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma. ( Auner, HW; Boyd, K; Brown, S; Garg, M; Hall, A; Kaiser, M; Kendall, J; Roberts, S, 2022)
"Men with high-risk non-metastatic prostate cancer are treated with androgen-deprivation therapy (ADT) for 3 years, often combined with radiotherapy."2.82Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. ( Alzoueb, M; Amos, CL; Atako, N; Attard, G; Birtle, A; Bowen, J; Brawley, C; Brown, LC; Buckner, M; Chowdhury, S; Clarke, NW; Cook, A; Cross, W; Das, P; de Bono, JS; Dearnaley, DP; Gale, J; Gilbert, D; Gillessen, S; Gilson, C; Gray, E; James, ND; Jones, RJ; Langley, RE; Lydon, A; Malik, Z; Mason, MD; Matheson, D; Millman, R; Murphy, L; O'Sullivan, JM; Parikh, O; Parker, CC; Parmar, MKB; Pedley, I; Pugh, C; Robinson, A; Rush, H; Russell, JM; Srihari, N; Sydes, MR; Syndikus, I; Tanguay, J; Thalmann, G; Thomas, C; Wagstaff, J; Wylie, J; Zarkar, A, 2022)
"Of the 86 deaths not attributable to disease progression, 18 (<1%) were caused by a drug-related adverse event, as assessed by the investigator."2.79Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial. ( Castellano, D; Daugaard, G; De Porre, P; Galli, L; Garrido, JM; Géczi, L; George, DJ; Goon, B; Hotte, SJ; Lee, E; Londhe, A; Mainwaring, PN; McGowan, T; Molina, A; Naini, V; Saad, F; Souza, C; Sternberg, CN; Tay, MH; Todd, MB, 2014)
"Treatment with etoposide also evolved as a prognostic factor because the risk of CNS failure was significantly reduced after CHOEP (P=0."2.73Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). ( Boehme, V; Kaiser, U; Kloess, M; Loeffler, M; Pfreundschuh, M; Schmitz, N; Zeynalova, S, 2007)
"A 47 year old woman with a MALT lymphoma affecting the breast exclusively is reported."2.40[Primary MALT-type lymphoma of the breast]. ( Campo, E; Cervantes, F; Esteve, J; Montserrat, E; Rafel, M; Serra, A; Velasco, M, 1998)
"Prednisolone was started for granulocyte colony-stimulating factor (G-CSF)-induced aortitis, and symptoms and elevated serum inflammatory markers resolved rapidly, allowing early discontinuation of prednisolone."1.91Granulocyte colony-stimulating factor-induced aortitis with temporal arteritis and monoarthritis. ( Homma, Y; Honda, Y; Iida, K, 2023)
"Adults with ulcerative colitis and health-care professionals treating inflammatory bowel disease."1.72Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study. ( Barr, A; Bedford, H; Blackwell, S; Coates, E; Dames, N; Hind, D; Lee, M; Lobo, A; Probert, C; Sebastian, S; Shackley, P; Totton, N; Wickramasekera, N, 2022)
"Systemic steroid treatment improved the stenosis and no recurrence was observed."1.56Systemic steroid application for treatment of edematous anastomotic stenosis following delta-shaped anastomosis in laparoscopic distal gastrectomy: a case report. ( Arima, J; Hiramatsu, M; Kagota, S; Kobayashi, T; Sakane, J; Suzuki, Y; Taniguchi, K; Tsunematsu, I; Uchiyama, K, 2020)
"Histiocytic sarcoma is a rare lymphohematopoietic malignancy with aggressive clinical course and poor therapy response."1.48A Rare Case of Primary Histiocytic Sarcoma of the Stomach. ( Guenova, ML; Hristoskova, RG; Petkova, NY; Raynov, JI, 2018)
"Immune pancytopenia was diagnosed with bone marrow tests and the presence of autoantibodies; it promptly resolved after initiation of prednisolone therapy."1.43Immune pancytopenia after chemotherapy in a patient with diffuse large B-cell lymphoma. ( Nagai, Y; Nagashima, K; Sugita, Y; Tanaka, H, 2016)
"A 64-year-old man presented with diplopia, muscle weakness, a pulmonary nodule and mediastinal widening on a chest radiograph."1.42Lung cancer associated with seronegative myasthenia gravis. ( Abe, T; Aoki, T; Asano, K; Hayama, N; Horio, Y; Inomoto, C; Murata, N; Nagata, E; Niimi, K; Oguma, T; Sato, M; Takiguchi, H; Takizawa, S; Tanaka, J; Tomomatsu, H; Tomomatsu, K; Urano, T, 2015)
"He was diagnosed with minimal change nephrotic syndrome (MCNS) complicated with the recurrence of malignant thymoma."1.35[Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma]. ( Fujimoto, S; Fukuda, A; Fukudome, K; Hara, S; Iwatsubo, S; Kitamura, K; Komatsu, H; Nishiura, R; Sato, Y; Yamada, K, 2009)
"Diagnosis of a giant macroprolactinoma was made and cabergoline was started."1.35Misdiagnosis due to the hook effect in prolactin assay. ( Arda, N; Comlekci, A; Men, S; Yener, S; Yesil, S, 2008)
"Prednisolone treatment (50 mg daily) resulted in dramatic regression of recurrent mediastinal and pleural tumors, as well as improvement of pure red cell aplasia."1.34[Successful corticosteroid therapy of a recurrent thymoma with pure red cell aplasia]. ( Koshio, J; Maeda, T; Nagasawa, Y; Tsukada, H; Yokoyama, A, 2007)
"Acute lymphoblastic leukemia (ALL) can be cured with combination chemotherapy in over 75% of children, but the cause of treatment failure in the remaining patients is unknown."1.33Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. ( Cheng, C; Cheok, MH; den Boer, ML; Evans, WE; Holleman, A; Janka-Schaub, GE; Lugthart, S; Pieters, R; Pui, CH; Relling, MV; Yang, W, 2005)
"The patient was diagnosed as relapse of malignant lymphoma, mainly based on these radiological findings reflecting the mass with high cellularity which grows without destruction of existing vascular structure, and additional chemotherapy was given."1.32[A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging]. ( Aibe, H; Asayama, Y; Honda, H; Irie, H; Kakihara, D; Matake, K; Nakamura, K; Nakayama, T; Nishie, A; Ohga, S; Tajima, T; Yamamoto, N; Yoshimitsu, K, 2003)
"We describe a B cell chronic lymphocytic leukemia/lymphoma (B-CLL) patient with an adrenocortical adenoma."1.30Functional adrenocortical adenoma in a case with B cell chronic lymphoproliferative disorder. ( Adachi, M; Adachi, Y; Fukushima, H; Hinoda, Y; Imai, K; Takahashi, T, 1997)
" Combination of radiotherapy and chemotherapy can improve the survival rate, but the optimal dosage needs to be investigated further."1.28Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. ( Abe, M; Dodo, Y; Shibamoto, Y; Shima, N; Tsutsui, K; Yamabe, H, 1990)
"Treatment with prednisolone brought relief."1.28Endobronchial pseudolymphoma associated with Sjögren's syndrome. Report of a case. ( Kajiki, A; Kido, M; Kuroiwa, A; Miyazaki, N; Yamazaki, H; Yoashihara, S, 1989)

Research

Studies (129)

TimeframeStudies, this research(%)All Research%
pre-199026 (20.16)18.7374
1990's23 (17.83)18.2507
2000's25 (19.38)29.6817
2010's42 (32.56)24.3611
2020's13 (10.08)2.80

Authors

AuthorsStudies
Nagasawa, S1
Miyazaki, M1
Morita, Y1
Tanaka, K1
Yada, M1
Masumoto, A1
Motomura, K1
Attard, G2
Murphy, L1
Clarke, NW2
Cross, W1
Jones, RJ2
Parker, CC2
Gillessen, S2
Cook, A1
Brawley, C2
Amos, CL2
Atako, N1
Pugh, C1
Buckner, M1
Chowdhury, S2
Malik, Z1
Russell, JM2
Gilson, C2
Rush, H1
Bowen, J2
Lydon, A1
Pedley, I1
O'Sullivan, JM1
Birtle, A1
Gale, J2
Srihari, N1
Thomas, C2
Tanguay, J1
Wagstaff, J2
Das, P1
Gray, E2
Alzoueb, M1
Parikh, O2
Robinson, A2
Syndikus, I1
Wylie, J2
Zarkar, A2
Thalmann, G1
de Bono, JS2
Dearnaley, DP2
Mason, MD2
Gilbert, D1
Langley, RE1
Millman, R2
Matheson, D2
Sydes, MR2
Brown, LC1
Parmar, MKB2
James, ND2
Christian, MT1
Webb, NJ1
Woolley, RL1
Afentou, N1
Mehta, S1
Frew, E1
Brettell, EA1
Khan, AR1
Milford, DV1
Bockenhauer, D1
Saleem, MA1
Hall, AS1
Koziell, A1
Maxwell, H1
Hegde, S1
Finlay, ER1
Gilbert, RD1
Jones, C1
McKeever, K1
Cook, W1
Ives, N1
Ueno, M1
Takabatake, H1
Hata, A1
Kayahara, T1
Morimoto, Y1
Notohara, K1
Mizuno, M1
Sakae, H1
Mawatari, S1
Oda, K1
Tabu, K1
Kumagai, K2
Mizuno, K1
Nozuma, S1
Kitazono, I1
Kanmura, S1
Ido, A1
Horiuchi, Y1
Hashimoto, K2
Horikoshi, H1
Sano, A1
Kawamura, Y1
Fujita, N1
Kimata, M1
Ono, Y1
Obuchi, Y1
Makino, A1
Kaneko, M1
Kimura, F1
Itoh, K1
Tanaka, Y1
Choi, JH1
Lim, I1
Byun, BH1
Kim, BI1
Choi, CW1
Kang, HJ3
Shin, DY1
Lim, SM1
Kendall, J1
Hall, A1
Roberts, S1
Brown, S1
Boyd, K1
Auner, HW1
Garg, M1
Kaiser, M1
Coates, E1
Wickramasekera, N1
Barr, A1
Shackley, P1
Lee, M1
Hind, D1
Probert, C1
Sebastian, S1
Totton, N1
Blackwell, S1
Bedford, H1
Dames, N1
Lobo, A1
Ohwada, S3
Ishigami, K3
Yokoyama, Y3
Kazama, T3
Masaki, Y4
Takahashi, M3
Yoshii, S3
Yamano, HO3
Chiba, H3
Nakase, H3
Iida, K1
Honda, Y1
Homma, Y1
Onozato, Y1
Sasaki, Y1
Abe, Y1
Yaoita, T1
Yagi, M1
Mizumoto, N1
Shoji, M1
Kon, T1
Sakai, T2
Ueno, Y1
Arima, J1
Taniguchi, K1
Kobayashi, T1
Tsunematsu, I1
Kagota, S1
Sakane, J1
Suzuki, Y1
Uchiyama, K1
Hiramatsu, M1
Ono, K1
Ise, M1
Ikebe, D1
Sato, A1
Wang, X2
Sugawara, T1
Tsujimura, H1
Itami, M1
Hwang, YY1
Khong, PL1
Kwong, YL1
Kiyohara, Y1
Yoshikawa, S1
Otsuka, M1
Kondou, R1
Iizuka, A1
Nonomura, C1
Ohshima, K1
Urakami, K1
Kusuhara, M1
Nagashima, T1
Sugino, T1
Yamaguchi, K2
Akiyama, Y1
Spears, MR1
Ritchie, AWS1
Cross, WR1
Berthold, DR1
Adab, F1
Aung, S1
Birtle, AJ1
Brock, S1
Chakraborti, P1
Ferguson, C1
Hingorani, M1
Hoskin, PJ1
Lester, JF1
Malik, ZI1
McKinna, F1
McPhail, N1
Money-Kyrle, J1
O'Sullivan, J1
Protheroe, A1
Srihari, NN1
Bavcar, S1
de Vos, J1
Kessler, M1
de Fornel, P1
Buracco, P1
Murphy, S1
Hirschberger, J1
Argyle, DJ1
Martin, OA1
Price, J1
MacManus, M1
Fisher, R1
Roos, D1
O'Brien, P1
Macann, A1
Davis, S1
Tsang, R1
Christie, D1
McClure, B1
Joseph, D1
Jayamohan, J1
Seymour, JF1
Petkova, NY1
Hristoskova, RG1
Guenova, ML1
Raynov, JI1
Yamada, T1
Masuda, T1
Sakamoto, S1
Horimasu, Y1
Miyamoto, S1
Nakashima, T1
Iwamoto, H1
Hirata, S1
Fujitaka, K1
Hamada, H1
Sugiyama, E1
Hattori, N1
Ohe, M1
Hashino, S1
Naqi, N1
Ahmad, S1
Shah, I1
Khattak, J1
Lowry, L1
Smith, P1
Cunningham, D2
Linch, DC1
Lee, JW1
Shin, HY1
Kim, H1
Park, JD1
Park, KD1
Kim, HS1
Park, SH1
Wang, KC1
Ahn, HS1
Koh, K2
Tomizawa, D1
Moriya Saito, A1
Watanabe, T1
Miyamura, T1
Hirayama, M1
Takahashi, Y1
Ogawa, A1
Kato, K1
Sugita, K2
Sato, T2
Deguchi, T1
Hayashi, Y1
Takita, J1
Takeshita, Y1
Tsurusawa, M1
Horibe, K1
Mizutani, S1
Ishii, E1
Alig, SK1
Dreyling, M1
Seppi, B1
Aulinger, B1
Witkowski, L1
Rieger, CT1
Coiffier, B2
Federico, M1
Caballero, D1
Dearden, C1
Morschhauser, F1
Jäger, U1
Trümper, L2
Zucca, E1
Gomes da Silva, M1
Pettengell, R1
Weidmann, E1
d'Amore, F1
Tilly, H1
Zinzani, PL1
Dahut, WL1
Madan, RA1
Sternberg, CN1
Castellano, D1
Daugaard, G2
Géczi, L1
Hotte, SJ1
Mainwaring, PN1
Saad, F1
Souza, C1
Tay, MH1
Garrido, JM1
Galli, L1
Londhe, A1
De Porre, P1
Goon, B1
Lee, E1
McGowan, T1
Naini, V1
Todd, MB1
Molina, A1
George, DJ1
Navinan, MR1
Liyanage, I1
Herath, S1
Yudhishdran, J1
Shivanthan, C1
Beneragama, D1
Kulatunga, A1
Fayad, L1
Ansell, SM1
Advani, R1
Stuart, R1
Bartlett, NL1
Forero-Torres, A1
Kuliczkowski, K1
Belada, D1
Ng, E1
Drachman, JG1
Vlenterie, M1
van Erp, NP1
van der Graaf, WT1
Tseng, YD1
Chen, YH1
Catalano, PJ1
Ng, A1
Paugh, SW1
Bonten, EJ1
Savic, D1
Ramsey, LB1
Thierfelder, WE1
Gurung, P1
Malireddi, RK1
Actis, M1
Mayasundari, A1
Min, J1
Coss, DR1
Laudermilk, LT1
Panetta, JC1
McCorkle, JR1
Fan, Y1
Crews, KR1
Stocco, G1
Wilkinson, MR1
Ferreira, AM1
Cheng, C2
Yang, W2
Karol, SE1
Fernandez, CA1
Diouf, B1
Smith, C1
Hicks, JK1
Zanut, A1
Giordanengo, A1
Crona, D1
Bianchi, JJ1
Holmfeldt, L1
Mullighan, CG1
den Boer, ML2
Pieters, R2
Jeha, S1
Dunwell, TL1
Latif, F1
Bhojwani, D1
Carroll, WL1
Pui, CH3
Myers, RM1
Guy, RK1
Kanneganti, TD1
Relling, MV2
Evans, WE2
Niimi, K1
Nagata, E1
Murata, N1
Sato, M1
Tanaka, J1
Horio, Y1
Takiguchi, H1
Tomomatsu, H1
Tomomatsu, K1
Hayama, N1
Oguma, T1
Aoki, T2
Urano, T1
Abe, T1
Inomoto, C1
Takizawa, S1
Asano, K1
Toyoshima, D1
Morisada, N1
Takami, Y1
Kidokoro, H1
Nishiyama, M1
Nakagawa, T1
Ninchoji, T1
Nozu, K1
Takeshima, Y1
Takada, S1
Nishio, H1
Iijima, K1
Beaven, AW1
Diehl, LF1
Friedberg, JW1
Kmieciak, L1
Hague, DW1
Neumann, ZL1
Joslyn, S1
Hedermann, G1
Marquart, HV1
Vissing, J1
Nagashima, K1
Tanaka, H1
Nagai, Y1
Sugita, Y1
Kwon, J1
Min, CK1
Kim, K1
Han, JJ1
Moon, JH1
Eom, HS1
Kim, MK1
Kim, HJ1
Yoon, DH1
Lee, JO1
Lee, WS1
Lee, JH1
Lee, JJ1
Choi, YS1
Kim, SH1
Yoon, SS1
Yener, S1
Comlekci, A1
Arda, N1
Men, S1
Yesil, S1
Fukuda, A1
Sato, Y1
Iwatsubo, S1
Komatsu, H1
Nishiura, R1
Fukudome, K1
Yamada, K1
Hara, S1
Fujimoto, S1
Kitamura, K1
Ito, J1
Sekiya, M1
Miura, K1
Yoshimi, K1
Suzuki, T1
Seyama, K1
Izumi, H1
Uekusa, T1
Takahashi, K1
Pan, CC1
Lee, WL1
Miki, M1
Nakamura, T3
Iwao, H1
Nakajima, A1
Sawaki, T1
Kawanami, T1
Kaito, M1
Kurose, N1
Fujita, Y1
Tanaka, M1
Fukushima, T2
Hirose, Y1
Umehara, H1
Hasegawa, D1
Manabe, A2
Ohara, A2
Kikuchi, A1
Kiyokawa, N1
Ishida, Y1
Saito, T2
Hanada, R2
Tsuchida, M2
Ono, M1
Ohnishi, S1
Onishi, R1
Takahashi, S1
Kobayashi, Y1
Suzuki, M1
Kubo, K1
Dazai, M1
Yamamoto, J1
Oda, H1
Tada, K1
Takahashi, T2
Miyagishima, T1
Shimada, K1
Greene, AK1
Couto, RA1
Mitteldorf, C1
Bertsch, HP1
Baumgart, M1
Haase, D1
Wulf, G1
Schön, MP1
Rosenwald, A1
Neumann, C1
Kaune, KM1
Chen, XG1
Huang, H1
Tian, Y1
Guo, CC1
Liang, CY1
Gong, YL1
Zou, BY1
Cai, RQ1
Lin, TY1
Nishioka, M1
Igawa, K1
Yahata, Y1
Tani, M1
Katayama, I2
Nakazawa, S2
Shimizu, K1
Nakano, T1
Kakegawa, S1
Atsumi, J1
Kamiyoshihara, M1
Hirato, J1
Takeyoshi, I1
Perry, CJ1
Sundar, S1
Rummel, MJ1
Mitrou, PS1
Hoelzer, D1
Katsumata, K2
Tomioka, H1
Kusama, M2
Koyanagi, Y2
McIntosh, SA1
Ogston, KN1
Payne, S1
Miller, ID1
Sarkar, TK1
Hutcheon, AW1
Heys, SD1
CLUXTON, HE1
Yamamoto, N1
Nishie, A1
Yoshimitsu, K1
Irie, H1
Aibe, H1
Tajima, T1
Asayama, Y1
Matake, K1
Nakayama, T1
Kakihara, D1
Ohga, S1
Nakamura, K1
Honda, H1
Hennequin, C1
Espié, M1
Misset, JL1
Maylin, C1
Ohta, M1
Takeshita, I1
Matsumoto, K1
Matsuoka, S1
Ikeda, K1
Lugthart, S1
Cheok, MH1
Holleman, A1
Janka-Schaub, GE1
Miller, MA1
Sandler, AD1
Yong, W1
Zheng, W1
Zhu, J1
Zhang, Y1
Wei, Y1
Lin, N1
Xie, Y1
Xu, B1
Li, J1
Ducray, F1
Colin, P1
Cartalat-Carel, S1
Pelissou-Guyotat, I1
Mahla, K1
Audra, P1
Gaucherand, P1
Honnorat, J1
Trouillas, P1
Magro, CM1
Seilstad, KH1
Porcu, P1
Morrison, CD1
Pascual, J1
Fernández, AM1
Marcén, R1
Ortuño, J1
Boehme, V1
Zeynalova, S1
Kloess, M1
Loeffler, M2
Kaiser, U1
Pfreundschuh, M1
Schmitz, N1
Mani, R1
Belcadhi, M1
Krifa, N1
Sriha, B1
Elomri, H1
Ben Ali, M1
Abdelkéfi, M1
Bouzouita, K1
Ushio, M1
Takeuchi, N1
Kikuchi, S1
Kaga, K1
Capra, M1
Hewitt, M1
Radford, M1
Hayward, J1
Weston, CL1
Machin, D1
Song, EK1
Kim, SY1
Kim, TM1
Lee, KW1
Yun, T1
Na, II1
Shin, H1
Lee, SH1
Kim, DW1
Khwarg, SI1
Heo, DS1
Koshio, J1
Tsukada, H1
Nagasawa, Y1
Maeda, T1
Yokoyama, A1
Rabadi, SJ1
Haid, M1
Scanlon, EF1
Khandekar, JD1
Caprini, JA1
Oviedo, MA1
Cunningham, MP1
Grizenko, KK1
Cohen, E1
Wilms, K1
Link, H1
Meyer, P1
Ostendorf, P1
Schüch, K1
Waller, HD1
Wernet, P1
Niethammer, D1
Dopfer, H1
Schneider, W1
Schunter, F1
Breitling, G1
Frommhold, W1
Seeger, G1
Voss, AC1
Vialushkin, BIa1
Koshel', IV1
Tsyplenkov, VG1
Monfardini, S1
Banfi, A1
Bonadonna, G1
Rilke, F1
Milani, F1
Valagussa, P1
Lattuada, A1
Gallmeier, WM1
Bruntsch, U1
Aki, T1
Ichikizaki, K1
Iwata, T1
Toya, S1
Nakano, S1
Timothy, AR1
Sutcliffe, SB1
Lister, TA1
Wrigley, PF1
Jones, AE1
Iba, T1
Yagi, Y1
Kidokoro, A1
Fukunaga, M1
Momose, F1
van Camp, C1
Clement, PA1
Toogood, IR1
Tiedemann, K1
Stevens, M1
Smith, PJ1
Bjerrum, OW1
Kiss, K1
Matsumoto, Y1
Terakado, H1
Ikawa, M1
Hamada, E1
Watanabe, Y1
Nakasato, S1
Takaki, S1
Murata, M1
Miura, T1
Levin, M1
Aziz, M1
Opitz, L1
Adachi, Y1
Adachi, M1
Hinoda, Y1
Fukushima, H1
Imai, K1
Ono, H1
Yokozeki, H1
Nishioka, K1
Yamamoto, K1
Shibata, K1
Murano, A1
Kawasaki, M1
Moriwaki, R1
Nagakawa, Y1
Ogata, T1
Emura, I1
Chou, T1
Ishiguro, T1
Kakihara, T1
Naito, M1
Yoshizawa, H1
Arakawa, M1
Veness, MJ1
Rafel, M1
Esteve, J1
Cervantes, F1
Velasco, M1
Serra, A1
Campo, E1
Montserrat, E1
Pichler, R1
Hatzl-Griesenhofer, M1
Huber, H1
Wimmer, G1
Wahl, G1
Maschek, W1
Wu, HG1
Kim, IH1
Ha, SW1
Park, CI1
Bang, YJ1
Huh, DS1
Guenther, PP1
Huebner, A1
Sobottka, SB1
Neumeister, V1
Weissbach, G1
Todt, H1
Parwaresch, R1
Ikuta, K1
Toyoda, Y1
Okimoto, Y1
Ishimoto, K1
Okawa, H1
Kaneko, T1
Koike, K1
Bessho, F1
Hoshi, Y1
Maeda, M1
Kinoshita, A1
Tsunematsu, Y1
Rübe, C1
Nguyen, TP1
Klöss, M1
Pfreunschuh, M1
Ingram, RM1
Williams, ME1
Fintel, WA1
Ross, M1
Murphy, GP1
Leventhal, BG1
Levine, AS1
Graw, RG1
Simon, R1
Freireich, EJ1
Henderson, ES1
Gilbert, HA1
Yettra, M1
Gordon, J1
Kagan, AR1
Kristensen, B1
Ejlertsen, B1
Holmegaard, SN1
Krarup-Hansen, A1
Transbøl, I1
Mouridsen, H1
Oza, AM1
Ganesan, TS1
Dorreen, M1
Johnson, PW1
Waxman, J1
Gregory, W1
Lim, J1
Wright, J1
Dadiotis, L1
Barbounis, V1
Singletary, SE1
McNeese, MD1
Hortobagyi, GN1
Nakagawa, H1
Tanaka, S1
Takashima, T1
Shizumi, Y1
Nishigaki, H1
Horiike, S1
Taniwaki, M1
Misawa, S1
Kashima, K1
Hironaka, T1
Perren, TJ1
Selby, PJ1
Milan, S1
Meldrum, M1
McElwain, TJ1
Atkinson, K1
Biggs, J1
Concannon, A1
Dodds, A1
Young, S1
Wilson, F1
Ashby, M1
Downs, K1
Anderson, H1
Crowther, D1
Deakin, DP1
Ryder, WD1
Radford, JA1
Dahl, GV1
Kalwinsky, DK1
Mirro, J1
Look, AT1
Murphy, SB1
Mason, C1
Ruggiero, M1
Schell, M1
Johnson, FL1
Shibamoto, Y1
Tsutsui, K1
Dodo, Y1
Yamabe, H1
Shima, N1
Abe, M1
Yamazaki, H2
Kuraishi, Y1
Takasaki, N1
Ozeki, H1
Mashizu, N1
Nagamine, D1
Usui, N1
Aiba, K1
Yokoyama, K1
Hepplestone, A1
Gilchrist, NL1
Dagg, JH1
Evans, IL1
Soukop, M1
Yoshida, T1
Nakamura, S1
Ohtake, S1
Kobayashi, K1
Kanno, M1
Matsuda, T1
Matano, S1
Kondo, K1
Okafuji, K1
Kanai, M1
Miyazaki, N1
Kido, M1
Kajiki, A1
Yoashihara, S1
Kuroiwa, A1
Domingo Albós, A1
Callís, M1
Juliá, A1
Vilá, J1
Zuazu, J1
Puig, J1
Petit, J1
Fernández-Sevilla, A1
O'Grady, JG1
Johnson, PJ1
Zaman, S1
Calne, RY1
Williams, R1
van Eys, J1
Berry, D1
Crist, W1
Doering, E1
Fernbach, D1
Pullen, J1
Shuster, J1
Wharam, M1
Tsukasaki, K1
Ikeda, S1
Momita, S1
Nagai, K1
Murata, K1
Tokunaga, S1
Kohno, T1
Itoyama, T1
Toriya, K1
Kuriyama, K1
Baĭsogolov, GD1
Pavlov, VV1
Shakhtarina, SV1
Mustiatsé, LZ1
Korchmaru, IF1
Ito, Y1
Hoshino, A1
Ohara, K1
Kamiya, O1
Nagata, K1
Kojima, T1
Kinoshita, T1
Sugiura, I1
Akagawa, S1
Murota, N1
Tanoue, M1
Ohdama, S1
Chida, M1
Miyazato, I1
Matsubara, O1
Tanaka, T1
Mitsunaga, K1
Van der Riet, Fde S1
Kahn, LB1
Berglund, G1
Vishniakova, EG1

Clinical Trials (9)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy: A Multi-Stage Multi-Arm Randomised Controlled Trial[NCT00268476]Phase 2/Phase 311,992 participants (Actual)Interventional2005-07-08Active, not recruiting
Safety and Efficacy Evaluation of Low-dose Nivolumab in Combination With AVD as Frontline Therapy for Classic Hodgkin's Lymphoma[NCT05772624]Phase 216 participants (Anticipated)Interventional2023-02-13Recruiting
A Randomized Phase II Trial Comparing Biomarker Directed Therapy Versus Clinician's Choice of Enzalutamide or Docetaxel in Patients With Advanced Prostate Cancer Post Abiraterone[NCT04015622]Phase 2100 participants (Anticipated)Interventional2020-10-07Recruiting
A Single-center, Phase II Neoadjuvant Study of Abiraterone Acetate in the Treatment of Intraductal Carcinoma of the Prostate[NCT04736108]Phase 250 participants (Anticipated)Interventional2021-05-31Not yet recruiting
An Open-label, Phase I/IIa Dose Escalation and Expansion Study to Determine the Safety and Clinical Activity of an Immune Priming Cell Therapy (INKmune) in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)[NCT06056791]Phase 1/Phase 230 participants (Anticipated)Interventional2023-11-30Not yet recruiting
A Randomised Multicentre Trial of Involved Field Radiotherapy Versus Involved Field Radiotherapy Plus Chemotherapy in Combination With Rituximab (Mabthera®) for Stage I - II Low Grade Follicular Lymphoma[NCT00115700]Phase 3150 participants (Actual)Interventional2000-02-29Completed
An Open Label Study of Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy[NCT01217697]0 participants Expanded AccessApproved for marketing
A Randomized Phase IIb Placebo-controlled Study of R-ICE Chemotherapy With and Without SGN-40 (Anti-CD40 Humanized Monoclonal Antibody) for Second-line Treatment of Patients With Diffuse Large B-Cell Lymphoma (DLBCL)[NCT00529503]Phase 2151 participants (Actual)Interventional2007-09-30Terminated
Total XV - Total Therapy Study XV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia[NCT00137111]Phase 3501 participants (Actual)Interventional2000-07-08Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Circulating Leukemia Cells in Peripheral Blood Change From Prior to the Methotrexate Infusion to Three Days After Between Two Arms (4 Hours vs. 24 Hours)

"White blood cell (leukocytes) counts in peripheral blood by Complete Blood Count~Measurement: Percentage change of leukemia cells from baseline" (NCT00137111)
Timeframe: Immediately before the methotrexate infusion and three days after subsequent infusion

InterventionPercent change (Mean)
4 hr-44
24 hr-50

Continuous Complete Remission Since Week 56 Therapy.

CCR was measured from end of week 56 therapy to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Measurement was determined by Kaplan-Meyer estimate. (NCT00137111)
Timeframe: Median follow up time (range) 4.5 (1 to 7.8) years

InterventionPercentage of participants (Number)
Patients With High Risk of CNS Relapse92.2

Mean Difference of Active Methotrexate Polyglutamates (MTXPG) in Leukemia Cells Between Two Arms (4 Hours vs. 24 Hours).

Children were randomly assigned to receive initial single-agent treatment with HDMTX (1g/m^2) as either a 24-hour infusion or a 4-hour infusion and the outcome measure was the accumulation of MTXPG in leukemia cells. (NCT00137111)
Timeframe: 42 hours after start of high dose methotrexate infusion (HDMTX)

Interventionpmol/1,000,000,000 cells (Mean)
4 hr1688
24 hr2521

Overall Event-free Survival (EFS)

EFS was measured from the start of on-study to the date of first treatment failure of any kind (relapse, death, lineage switch, or second malignancy) or to the last date of follow-up. Failure to enter remission was considered an event at time zero. Measurement was determined by Kaplan-Meyer estimate. (NCT00137111)
Timeframe: Median follow-up time (range) 5.6 (1.3 to 8.9) years

InterventionPercentage of Participants (Number)
Total Therapy87.3

Median Difference in CASP1 Gene Expression in Primary Leukemia Cells of Patients in Glucocorticoid-resistant Cells vs Glucocorticoid-sensitive Cells

Prednisolone sensitivity was measured in primary leukemia cells from bone marrow collected at diagnosis. Expression of CASP1 was determined by HG-U133A microarray. Values given are gene expression values, and the unit is arbitrary units (AU) defined as scaled fluorescence measured on microarray. (NCT00137111)
Timeframe: Pre-treatment

Interventionarbitrary units (Median)
Prednisolone-sensitive cellsPrednisolone-resistant cells
Total Therapy341.3447.9

Median Difference in NLRP3 Gene Expression in Primary Leukemia Cells of Patients in Glucocorticoid-resistant Cells vs. Glucocorticoid-sensitive Cells

Prednisolone sensitivity was measured in primary leukemia cells from bone marrow collected at diagnosis. Expression of NLRP3 was determined by HG-U133A microarray. Values given are gene expression values, and the unit is arbitrary units (AU) defined as scaled fluorescence measured on microarray. (NCT00137111)
Timeframe: Pre-treatment

Interventionarbitrary units (Median)
Prednisolone-sensitive cellsPrednisolone-resistant cells
Total Therapy41.2110.7

Minimal Residual Disease (MRD)

Detection of MRD at end of induction where positive MRD was defined as one or more leukemic cell per 10,000 mononuclear bone-marrow cells (>=0.01%). (NCT00137111)
Timeframe: End of Induction (Day 46 MRD measurement)

Interventionparticipants (Number)
Negative <0.01%Positive >= 0.01%
Total Therapy390102

Reviews

12 reviews available for prednisolone and Local Neoplasm Recurrence

ArticleYear
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
    Lancet (London, England), 2022, 01-29, Volume: 399, Issue:10323

    Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chemotherapy, Adjuv

2022
Mycophenolate mofetil for immune checkpoint inhibitor-related hepatotoxicity relapsing during dose reduction of corticosteroid: A report of two cases and literature review.
    Cancer reports (Hoboken, N.J.), 2022, Volume: 5, Issue:9

    Topics: Adrenal Cortex Hormones; Aged; Chemical and Drug Induced Liver Injury; Drug Tapering; Humans; Immune

2022
Cronkhite-Canada Syndrome Associated with Gastric Outlet Obstruction and Membranous Nephropathy: A Case Report and Review of the Literature.
    Internal medicine (Tokyo, Japan), 2020, Nov-15, Volume: 59, Issue:22

    Topics: Gastric Outlet Obstruction; Glomerulonephritis, Membranous; Humans; Intestinal Polyposis; Male; Midd

2020
Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature.
    European journal of haematology, 2015, Volume: 94, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclopho

2015
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
    Cancer treatment reviews, 2014, Volume: 40, Issue:9

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemo

2014
Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach.
    Hematology. American Society of Hematology. Education Program, 2015, Volume: 2015

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Genotype; Humans; Imm

2015
[Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
    Brain and nerve = Shinkei kenkyu no shinpo, 2011, Volume: 63, Issue:5

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C

2011
Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
    Seminars in oncology, 2002, Volume: 29, Issue:4 Suppl 13

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplasti

2002
[Does primary chemotherapy really increase the rate of breast conserving treatments?].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2004, Volume: 8, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Cy

2004
[Primary MALT-type lymphoma of the breast].
    Sangre, 1998, Volume: 43, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph

1998
Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrence.
    Clinical lymphoma, 2002, Volume: 2, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Cyclophos

2002
Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma.
    International journal of hematology, 1991, Volume: 54, Issue:3

    Topics: Aclarubicin; Adolescent; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Carcinoma, Hepatoce

1991

Trials

23 trials available for prednisolone and Local Neoplasm Recurrence

ArticleYear
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Health technology assessment (Winchester, England), 2022, Volume: 26, Issue:3

    Topics: Child; Child, Preschool; Cost-Benefit Analysis; Humans; Neoplasm Recurrence, Local; Nephrotic Syndro

2022
MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma.
    BMJ open, 2022, 10-26, Volume: 12, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Cyclophosphamide

2022
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
    The New England journal of medicine, 2017, 07-27, Volume: 377, Issue:4

    Topics: Abiraterone Acetate; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined C

2017
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 10-10, Volume: 36, Issue:29

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cyclophosphamide; Fe

2018
A multicentre phase-II feasibility study evaluating gemcitabine/vinorelbine / prednisolone combination chemotherapy in relapsed / refractory Hodgkin's lymphoma.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2013, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chil

2013
Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
    Pediatric hematology and oncology, 2014, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined

2014
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial.
    The Lancet. Oncology, 2014, Volume: 15, Issue:11

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Androstenes; Androstenol

2014
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placeb
    Leukemia & lymphoma, 2015, Volume: 56, Issue:9

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carb

2015
The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.
    Pediatric blood & cancer, 2012, Volume: 58, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Central Nervous Sy

2012
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cyclophosphamide

2007
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy.
    Journal of surgical oncology, 1984, Volume: 26, Issue:4

    Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Breast Neoplasm

1984
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
    International journal of radiation oncology, biology, physics, 1980, Volume: 6, Issue:2

    Topics: Actuarial Analysis; Adult; Aged; Clinical Trials as Topic; Cobalt Radioisotopes; Cyclophosphamide; D

1980
The management of stage IIIA Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1980, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di

1980
[Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration S

1995
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:2

    Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burki

1993
[Intra-arterial infusion chemotherapy for breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Fema

1996
Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas.
    Journal of Korean medical science, 1999, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous

1999
Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
    Annals of hematology, 2001, Volume: 80 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease

2001
[Chemotherapy of advanced prostate cancer].
    Voprosy onkologii, 1977, Volume: 23, Issue:12

    Topics: Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Diethylstilbestrol; Drug Eval

1977
Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study.
    Journal of internal medicine, 1992, Volume: 232, Issue:3

    Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Calcium; Female; Fluid Therapy; Furosemide; Hum

1992
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
    Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:6

    Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease;

1991
A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female

1991
A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
    Cancer, 1989, Jan-01, Volume: 63, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Presc

1989

Other Studies

94 other studies available for prednisolone and Local Neoplasm Recurrence

ArticleYear
[A case of pembrolizumab-induced sclerosing cholangitis that was responsive to high-dose steroid therapy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2021, Volume: 118, Issue:10

    Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Cholangitis, Sclerosing; Female; Humans; Neopl

2021
A case of autoimmune hepatitis with thymoma and myasthenia gravis.
    Clinical journal of gastroenterology, 2022, Volume: 15, Issue:4

    Topics: Adult; Female; Hepatitis, Autoimmune; Humans; Myasthenia Gravis; Neoplasm Recurrence, Local; Prednis

2022
Fulminant elderly adult-onset Still disease effectively treated with tocilizumab and methotrexate: A case report.
    Medicine, 2022, Jul-15, Volume: 101, Issue:28

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Disseminated Intravascular Coagul

2022
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.
    PloS one, 2022, Volume: 17, Issue:9

    Topics: Adult; Aged; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Femal

2022
Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study.
    Health technology assessment (Winchester, England), 2022, Volume: 26, Issue:41

    Topics: Adult; Colitis, Ulcerative; Cost-Benefit Analysis; COVID-19; Humans; Infliximab; Neoplasm Recurrence

2022
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Immune-related colitis and pancreatitis treated with infliximab.
    Clinical journal of gastroenterology, 2023, Volume: 16, Issue:1

    Topics: Colitis; Cytokines; Diarrhea; Humans; Infliximab; Male; Middle Aged; Neoplasm Recurrence, Local; Pan

2023
Granulocyte colony-stimulating factor-induced aortitis with temporal arteritis and monoarthritis.
    BMJ case reports, 2023, Feb-07, Volume: 16, Issue:2

    Topics: Aortitis; Arthritis; Filgrastim; Giant Cell Arteritis; Granulocyte Colony-Stimulating Factor; Humans

2023
Systemic steroid application for treatment of edematous anastomotic stenosis following delta-shaped anastomosis in laparoscopic distal gastrectomy: a case report.
    BMC surgery, 2020, Jul-22, Volume: 20, Issue:1

    Topics: Administration, Intravenous; Aged; Anastomosis, Surgical; Constriction, Pathologic; Dilatation; Edem

2020
Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm.
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2017, Volume: 58, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dendritic Cells

2017
Low-dose nivolumab induced remission in refractory classical Hodgkin lymphoma.
    Annals of hematology, 2017, Volume: 96, Issue:7

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol

2017
Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.
    The Journal of dermatology, 2017, Volume: 44, Issue:10

    Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; B7-H1 Antigen; Biomarkers, Tumor; Bone Neoplasm

2017
Combination toceranib and lomustine shows frequent high grade toxicities when used for treatment of non-resectable or recurrent mast cell tumours in dogs: A European multicentre study.
    Veterinary journal (London, England : 1997), 2017, Volume: 224

    Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dog Dise

2017
Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
    Journal of feline medicine and surgery, 2018, Volume: 20, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Disease-Free Survival;

2018
A Rare Case of Primary Histiocytic Sarcoma of the Stomach.
    Folia medica, 2018, Jun-01, Volume: 60, Issue:2

    Topics: Abdomen; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophospham

2018
Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis.
    Internal medicine (Tokyo, Japan), 2019, Nov-01, Volume: 58, Issue:21

    Topics: Aged; Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Glucocortico

2019
Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide.
    The Korean journal of internal medicine, 2013, Volume: 28, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Cyclophospham

2013
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy.
    Journal of geriatric oncology, 2013, Volume: 4, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cau

2013
Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.
    Leukemia, 2015, Volume: 29, Issue:2

    Topics: Antineoplastic Agents; Child, Preschool; Disease-Free Survival; Female; Gene Rearrangement; Hematopo

2015
Real-world experience with abiraterone.
    The Lancet. Oncology, 2014, Volume: 15, Issue:11

    Topics: Androstenes; Androstenols; Humans; Male; Neoplasm Recurrence, Local; Prednisolone; Prostate-Specific

2014
Inoperable inflammatory myofibroblastic tumour of the para-nasal sinuses and orbit with recurrence responding to methotrexate and prednisolone: a case report.
    BMC research notes, 2015, Feb-04, Volume: 8

    Topics: Adult; Antimetabolites, Antineoplastic; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Me

2015
Promising management of pazopanib-induced liver toxicity.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:7

    Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Female; H

2015
Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma.
    International journal of radiation oncology, biology, physics, 2015, Jan-01, Volume: 91, Issue:1

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophospha

2015
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
    Nature genetics, 2015, Volume: 47, Issue:6

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Base Sequence; Carrier Proteins; Caspase 1; Child; Chil

2015
Lung cancer associated with seronegative myasthenia gravis.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:11

    Topics: Blepharoptosis; Diplopia; Fatal Outcome; Humans; Lung Neoplasms; Male; Middle Aged; Myasthenia Gravi

2015
Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
    Brain & development, 2016, Volume: 38, Issue:3

    Topics: Child, Preschool; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Opsoclonus-Myoclonus Synd

2016
Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma.
    Hematology. American Society of Hematology. Education Program, 2015, Volume: 2015

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Fre

2015
What Is Your Neurologic Diagnosis? Nasopharyngeal lymphoma.
    Journal of the American Veterinary Medical Association, 2016, Mar-15, Volume: 248, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cat Diseases; Cats; Chemoradi

2016
Polymyositis following autologous haematopoietic stem cell transplantation.
    Scandinavian journal of rheumatology, 2016, Volume: 45, Issue:5

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy

2016
Immune pancytopenia after chemotherapy in a patient with diffuse large B-cell lymphoma.
    BMJ case reports, 2016, Sep-20, Volume: 2016

    Topics: Aged, 80 and over; Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemothe

2016
Efficacy and toxicity of the combination chemotherapy of thalidomide, alkylating agent, and steroid for relapsed/refractory myeloma patients: a report from the Korean Multiple Myeloma Working Party (KMMWP) retrospective study.
    Cancer medicine, 2017, Volume: 6, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemother

2017
Misdiagnosis due to the hook effect in prolactin assay.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2008, Volume: 17, Issue:5

    Topics: Antineoplastic Agents; Cabergoline; Diabetes Insipidus, Neurogenic; Diagnostic Errors; Ergolines; Fe

2008
[Minimal change nephrotic syndrome complicated with recurrence of malignant thymoma: an interesting case with remission due to steroid therapy of both nephrotic syndrome and thymoma].
    Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:2

    Topics: Aged; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Neoplasm Recu

2009
Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:12

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclopho

2009
Vaginal obliteration in a woman with a history of cutaneous T-cell lymphoma: the results of combined chemotherapy-induced gonadal toxicity and lymphoma relapse.
    Taiwanese journal of obstetrics & gynecology, 2010, Volume: 49, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophos

2010
[Primary neurolymphomatosis of the cervical nerve root].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:7

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot

2010
[Repetition of Helicobacter cinaedi infections during chemotherapy for malignant lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefozopran; Cephalospor

2010
Oral prednisolone for infantile hemangioma: efficacy and safety using a standardized treatment protocol.
    Plastic and reconstructive surgery, 2011, Volume: 128, Issue:3

    Topics: Administration, Oral; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administratio

2011
Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; CD56 Antigen; Ch

2011
Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen.
    Chinese journal of cancer, 2011, Volume: 30, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; D

2011
Simultaneous occurrence of dermatomyositis and systemic sarcoidosis with recurrent breast cancer.
    The Journal of dermatology, 2012, Volume: 39, Issue:5

    Topics: Aged; Breast Neoplasms; Dermatomyositis; Female; Humans; Neoplasm Recurrence, Local; Prednisolone; S

2012
An immunoglobulin G4-related disease mimicking postoperative lung cancer recurrence.
    Modern rheumatology, 2012, Volume: 22, Issue:5

    Topics: Aged; Autoimmune Diseases; Diagnosis, Differential; Fluorodeoxyglucose F18; Glucocorticoids; Humans;

2012
Cabazitaxel rechallenge at prostate-specific antigen relapse after previous cabazitaxel and docetaxel chemotherapy: case report.
    Clinical genitourinary cancer, 2012, Volume: 10, Issue:3

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug R

2012
Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitox

2003
Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy.
    American journal of surgery, 2003, Volume: 185, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ch

2003
A new approach to the medical management of primary hypophysectomy in the treatment of recurrent carcinoma of the breast.
    Quarterly bulletin. Northwestern University (Evanston, Ill.). Medical School, 1958, Volume: 32, Issue:4

    Topics: Breast; Breast Neoplasms; Carcinoma; Humans; Hypophysectomy; Mastectomy; Neoplasm Recurrence, Local;

1958
[A case of isolated hepatic malignant lymphoma representing characteristic findings on radiological imaging].
    Fukuoka igaku zasshi = Hukuoka acta medica, 2003, Volume: 94, Issue:11

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptoth

2003
[Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].
    No shinkei geka. Neurological surgery, 2005, Volume: 33, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cytarabine; Fatal

2005
Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
    Cancer cell, 2005, Volume: 7, Issue:4

    Topics: Age Factors; Antineoplastic Agents; Asparaginase; Cell Survival; Child; Cluster Analysis; Core Bindi

2005
Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma.
    Journal of pediatric surgery, 2005, Volume: 40, Issue:5

    Topics: Biomarkers, Tumor; Hemangioendothelioma; Hepatectomy; Hip Contracture; Humans; Infant; Liver Neoplas

2005
Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Hematological oncology, 2006, Volume: 24, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspa

2006
[Management of malignant gliomas diagnosed during pregnancy].
    Revue neurologique, 2006, Volume: 162, Issue:3

    Topics: Abortion, Therapeutic; Adrenal Cortex Hormones; Adult; Algorithms; Anesthesia, General; Antineoplast

2006
Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement.
    American journal of clinical pathology, 2006, Volume: 126, Issue:1

    Topics: Aged; Antigens, CD; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; CD8 Antigens; Cy

2006
Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21 Suppl 3

    Topics: Blood Pressure; Calcineurin Inhibitors; Creatinine; Cyclosporine; Drug Therapy, Combination; Everoli

2006
[NK/T-Cell lymphoma of nasopharynx].
    Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Societe d'oto-laryngologie des hopitaux de Paris, 2006, Volume: 123, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Cyclophosp

2006
Inflammatory pseudotumour of the paranasal sinuses--a case report.
    Auris, nasus, larynx, 2007, Volume: 34, Issue:4

    Topics: Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Diplopia; Disease Progression; Female; Gr

2007
Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial.
    European journal of cancer (Oxford, England : 1990), 2007, Volume: 43, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; D

2007
Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone B-cell lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Dose-

2008
[Successful corticosteroid therapy of a recurrent thymoma with pure red cell aplasia].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2007, Volume: 45, Issue:11

    Topics: Aged; Humans; Male; Neoplasm Recurrence, Local; Pleural Neoplasms; Prednisolone; Red-Cell Aplasia, P

2007
[Bone marrow transplantation in patients with leukemia].
    Klinische Wochenschrift, 1982, Oct-15, Volume: 60, Issue:20

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Female; Graf

1982
[Treatment procedure in generalized lymphogranulomatosis in children].
    Pediatriia, 1982, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1982
[Drug therapy of Hodgkin's disease].
    Der Internist, 1981, Volume: 22, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho

1981
[A case of primary malignant lymphoma of the brain which showed a remarkable response to prednisolone].
    No to shinkei = Brain and nerve, 1982, Volume: 34, Issue:10

    Topics: Antineoplastic Agents; Basal Ganglia; Brain Neoplasms; Humans; Lymphoma; Male; Middle Aged; Neoplasm

1982
Results of oral steroid treatment in nasal polyposis.
    Rhinology, 1994, Volume: 32, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aspirin; Combined Modality Therapy; Drug Hypersensitivity; Female

1994
Combination chemotherapy with a five-drug regimen for invasive thymoma.
    Acta oncologica (Stockholm, Sweden), 1996, Volume: 35, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormon

1996
Steroid-responsive interstitial pneumonitis after fludarabine therapy.
    Chest, 1997, Volume: 111, Issue:5

    Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Cough; Fatal Outcome; Glucocorticoids; Humans

1997
Functional adrenocortical adenoma in a case with B cell chronic lymphoproliferative disorder.
    Acta haematologica, 1997, Volume: 97, Issue:4

    Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenalectomy; Antineoplastic Combined C

1997
Granuloma annulare in a patient with malignant lymphoma.
    Dermatology (Basel, Switzerland), 1997, Volume: 195, Issue:1

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormona

1997
[Efficacy of combination chemotherapy with mitoxantrone, vincristine, doxifluridine and prednisolone for recurrence of breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:15

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms;

1997
Proportion of blasts with a clear halo around nucleoli at the end of induction therapy of acute myeloid leukemia correlates with achievement of complete remission, remission duration and relapse.
    Pathology international, 1998, Volume: 48, Issue:7

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Prot

1998
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe?
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:3

    Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cy

1998
[Primary lymphoma of the thyroid with contralateral recurrence--case report].
    Wiener klinische Wochenschrift, 1999, Apr-23, Volume: 111, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Dexamethasone; Epirubici

1999
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiatio

2001
Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jul-01, Volume: 19, Issue:13

    Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Child, Preschool; Disease-Free Survival; Drug Sc

2001
Long-term second remissions in acute lymphatic leukemia.
    Cancer, 1975, Volume: 35, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat

1975
On long-term survivals in non-Hodgkin's lymphoma with 'gentle' treatment.
    Clinical radiology, 1976, Volume: 27, Issue:2

    Topics: Adult; Aged; Child; Chlorambucil; Female; Follow-Up Studies; Humans; Lymph Nodes; Lymphoma; Male; Mi

1976
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
    British journal of cancer, 1992, Volume: 65, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microgl

1992
Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma.
    Cancer, 1992, Jun-01, Volume: 69, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Co

1992
Etoposide and adriamycin containing combination chemotherapy (HOPE-Bleo) for relapsed Hodgkin's disease.
    British journal of cancer, 1990, Volume: 61, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Doxorubic

1990
Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chil

1990
Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.
    Cancer, 1990, May-01, Volume: 65, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined M

1990
[Patterns of relapse in non-Hodgkin's lymphoma after complete remission induced by combination chemotherapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1985, Volume: 26, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

1985
Failure of conventional chemotherapy in aggressive lymphomas.
    Postgraduate medical journal, 1987, Volume: 63, Issue:735

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubici

1987
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:2

    Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide;

1989
Endobronchial pseudolymphoma associated with Sjögren's syndrome. Report of a case.
    Endoscopy, 1989, Volume: 21, Issue:2

    Topics: Bronchial Neoplasms; Female; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Prednisolone

1989
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas].
    Sangre, 1989, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug

1989
Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression.
    Transplantation proceedings, 1988, Volume: 20, Issue:3 Suppl 3

    Topics: Azathioprine; Carcinoma, Hepatocellular; Cyclosporins; Humans; Liver Neoplasms; Liver Transplantatio

1988
[Effect of combination chemotherapy with cis-dichlorodiammineplatinum on relapsed or therapy-resistant non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1988, Volume: 29, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubici

1988
[Course of lymphogranulomatosis with primary location below the diaphragm].
    Meditsinskaia radiologiia, 1988, Volume: 33, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diaphragm; Female; Hodgkin

1988
[Therapy against relapse in generalized lymphoblastic and immunoblastic lymphosarcomas in complete remission].
    Terapevticheskii arkhiv, 1986, Volume: 58, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Eval

1986
[Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:10

    Topics: Adult; Aged; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclo

1985
[A case of pulmonary pseudolymphoma, presenting various symptoms, and responding remarkably to corticosteroid therapy].
    Nihon Kyobu Shikkan Gakkai zasshi, 1985, Volume: 23, Issue:10

    Topics: Adult; Humans; Lung Neoplasms; Lymphoma; Male; Neoplasm Recurrence, Local; Prednisolone

1985
Attempted induction of sarcoma in a Cape Chacma baboon with the Snyder-Theilen feline sarcoma virus.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1973, Jun-09, Volume: 47, Issue:22

    Topics: Animals; Antilymphocyte Serum; Azathioprine; Cats; Fibrosarcoma; Haplorhini; Immunity; Male; Neoplas

1973
[Prognosis in leukemia of childhood].
    Lakartidningen, 1972, Jan-19, Volume: 69, Issue:4

    Topics: Adolescent; Antineoplastic Agents; BCG Vaccine; Child; Child, Preschool; Follow-Up Studies; Humans;

1972
[Hormonal prevention of recurrence and metastasis in the complex treatment of breast cancer].
    Voprosy onkologii, 1968, Volume: 14, Issue:3

    Topics: Adult; Aged; Androgens; Breast Neoplasms; Castration; Estrogens; Female; Humans; Mastectomy; Middle

1968